PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Sciences, University of Campania \'Luigi Vanvitelli\', Piazza Luigi Miraglia 2, 80138, Naples, Italy. miriam.longo@unicampania.it.\', \'Division of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Sciences, University of Campania \'Luigi Vanvitelli\', Piazza Luigi Miraglia 2, 80138, Naples, Italy.\', \'Diabetes Unit, Department of Advanced Medical and Surgical Sciences, University of Campania \'Luigi Vanvitelli\', Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12933-020-01090-9
?:hasPublicationType
?:journal
  • Cardiovascular diabetology
is ?:pmid of
?:pmid
?:pmid
  • 32698837
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.157
?:rankingScore_hIndex
  • 60
is ?:relation_isRelatedTo_publication of
?:title
  • Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all